Advertisement

Topics

ID Genomics Company Profile

01:14 EDT 15th August 2018 | BioPortfolio

ID Genomics is a Seattle-based health technology company that is developing diagnostics to guide antibiotic selection at the point-of-care. Its proprietary CLoNeT™ and BactNet™ DNA fingerprinting-based system leverages key discoveries in microbiology and bacterial genomics to improve patient outcomes, decrease healthcare costs, and ultimately reduce the spread of antimicrobial resistance. Research has shown that ID Genomics’ technology gives healthcare providers information about essential characteristics of the infecting bacteria, enabling them to accurately match a bug with correct drugs in less than 30 minutes. This technology is currently being in compliance with the Food and Drug Administration’s 510(k) clearance pathway. More information is available online at www.idgenomics.com.


News Articles [303 Associated News Articles listed on BioPortfolio]

Genomics England announces appointment of global genomics pioneer as first CEO

Genomics England announces the appointment of its first Chief Executive Officer (CEO) today. Global genomics pioneer Professor John Mattick will join Genomics England in June. He will lead the organiz...

Rosetta Genomics Ltd.: Genoptix Completes Acquisition of PersonalizeDx from Rosetta Genomics

-First step in the process of Genoptix acquiring all of Rosetta Genomics -Next step is the completion of a merger for $8 million in cash pursuant to which value to Rosetta Genomics' equity holders...

Nebula wants to democratise genome sequencing, with the help of blockchain and cryptocurrency

A new start-up has been launched with a dazzling, technology-enabled vision of putting genomics into the hands of the DNA’s owners – individuals – rather than what it calls genomics ‘middle me...

UCSF Names First Chief Genomics Officer

David RathsRecognizing that genomics is playing an increasingly important role in medicine, the University of California San Francisco Health has appointed its first chief genomics officer (CGO).

HL7 Meeting to Focus on Intersection of Clinical Genomics, AI

David RathsGrant Wood, a member of the HL7 Clinical Genomics Work Group and a senior strategist at Intermountain Healthcare’s Clinical Genetics Institute, talks about the confluence of genomics and ...

Rosetta Genomics Ltd.: Rosetta Genomics Announces Shareholder Approval of Merger with Genoptix

PHILADELPHIA, PA and REHOVOT, ISRAEL / ACCESSWIRE / April 26, 2018 / Rosetta Genomics Ltd. (the "Company") (NASDAQ: ROSG) today announced that its shareholders approved a proposed merger with a sub...

Genoptix plans to acquire Rosetta Genomics for $10mm in cash; transaction later terminated

Oncology diagnostic lab Genoptix Inc. agreed to acquire all outstanding shares of Nasdaq-traded Israeli genomics company Rosetta Genomics Ltd. (cancer diagnostics).

AI specialists join Genomics England’s drug discovery alliance

Lantern Pharma, a pharma company which uses artificial intelligence (AI) to develop previously-shelved oncology drugs, has joined Genomics England’s groundbreaking industry partnership. First lau...

Drugs and Medications [0 Results]

None

PubMed Articles [188 Associated PubMed Articles listed on BioPortfolio]

Recent developments of software and database in microbial genomics and functional genomics.

Utilization of Genomics and Functional Genomics to Inform Clinical Decisions in IR.

Single-cell genomics.

The Global Landscape of Nursing and Genomics.

Nurses have a pivotal role in bringing the benefits of genomics and precision medicine to everyday health care, but a concerted global effort is needed to transform nursing policy and practice to addr...

An Introduction to Integrative Genomics and Systems Medicine in Cancer.

In this Special Issue (SI), with a theme of "Integrative Genomics and Systems Medicine in Cancer", we have collected a total of 12 research and review articles from researchers in the field of genomic...

Clinical Trials [82 Associated Clinical Trials listed on BioPortfolio]

Electronic Medical Records and Genomics (eMERGE) Phase III

The Electronic Medical Records and Genomics (eMERGE) Network is in its third phase and during this time is enrolling and sequencing 25,000 individuals on a custom sequencing panel of clini...

Genomics and Postoperative Atrial Fibrillation

This research study is done to find out if genetic make up of a person plays a role in complications and recovery after the Coronary Artery Bypass Graft (CABG) operation. As you may be aw...

Microfluidics and Transcriptomics in Post Solid Organ Transplant Patients

The field of genomics is an exciting new field being applied in medicine. Its use in treating some cancers, sepsis and burn patients has been very promising. As knowledge of genomics and a...

High Throughput Drug Sensitivity and Genomics Data in Developing Individualized Treatment in Patients With Relapsed or Refractory Multiple Myeloma or Plasma Cell Leukemia

This pilot clinical trial studies whether using high throughput drug sensitivity and genomics data is feasible in developing individualized treatment in patients with multiple myeloma or p...

Inflammatory Genomics in Human Carotid Artery Disease

To investigate the relationship between genetic variation in genes for inflammation and carotid artery atherosclerosis.

Companies [404 Associated Companies listed on BioPortfolio]

Genomics in Business

In 2003 Keygene initiated the first edition of Genomics in Business. It was the first conference to focus on the existing and future applications of genomics in the Agro-Food industry. With participan...

Genomics One Corporation

Genomics One is a fully integrated biotechnology company committed to the creation of shareholder value through innovation in the fields of genomics, proteomics and mono-clonal antibodies. The mission...

Center for Genomics and Bioinformatics

Center for Genomics and Bioinformatics The Center for Genomics and Bioinformatics (CGB) was launched in 1997 as a new academic department at the Karolinska Institute. Since then, the department has be...

Front Line Genomics

At Front Line Genomics our mission is to help deliver the benefits of genomics faster. Through our website, our magazine and the Festivals of Genomics, we support scientists, clin...

Sure Genomics, Inc.

Sure Genomics is a personal genetics company dedicated to making personal DNA information accessible with unlimited DNA analysis over a person’s lifetime as new genetic disco...

More Information about "ID Genomics" on BioPortfolio

We have published hundreds of ID Genomics news stories on BioPortfolio along with dozens of ID Genomics Clinical Trials and PubMed Articles about ID Genomics for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of ID Genomics Companies in our database. You can also find out about relevant ID Genomics Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Bioinformatics
Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...


Corporate Database Quicklinks



Searches Linking to this Company Record